Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. 1997

D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
CRC Genetic Epidemiology Unit, Institute of Public Health, Cambridge, United Kingdom. douglas.easton@mrc-bsu.cam.ac.uk

The penetrance of the BRCA2 gene on chromosome 13q12-13 has been estimated in two large, systematically ascertained, linked families, by use of a maximum-likelihood method to incorporate both cancer-incidence data and 13q marker typings in the families. The cumulative risk of breast cancer in female gene carriers was estimated to be 59.8% by age 50 years (95% confidence interval [95% CI] 25.9%-78.5%) and 79.5% by age 70 years (95% CI 28.9%-97.5%). The cumulative risk of breast cancer in male carriers was estimated to be 6.3% (95% CI 1.4%-25.6%) by age 70 years. There was no evidence of any risk difference between the two families. These results indicate that the lifetime breast cancer risk in BRCA2 carriers, for at least a subset of mutations, is comparable to that for BRCA1. A significant excess of ovarian cancer in gene carriers was observed (relative risk 17.69, based on three cases), but the absolute risk of ovarian cancer was less than that reported for BRCA1. Significant excesses of laryngeal cancer (relative risk 7.67, based on two possible carriers) and prostate cancer (relative risk 2.89, based on five possible carriers) were also observed. One case of ocular melanoma, as well as a second eye cancer of unspecified histology, occurred in obligate gene carriers.

UI MeSH Term Description Entries
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002882 Chromosomes, Human, Pair 13 A specific pair of GROUP D CHROMOSOMES of the human chromosome classification. Chromosome 13
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
September 1994, Science (New York, N.Y.),
D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
February 1998, Diagnostic molecular pathology : the American journal of surgical pathology, part B,
D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
April 1995, Oncogene,
D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
January 1996, Proceedings of the National Academy of Sciences of the United States of America,
D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
November 1995, British journal of cancer,
D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
May 2000, Journal of medical genetics,
D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
October 2005, Journal of medical genetics,
D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
July 1996, Human genetics,
D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
September 2005, Journal of medical genetics,
D F Easton, and L Steele, and P Fields, and W Ormiston, and D Averill, and P A Daly, and R McManus, and S L Neuhausen, and D Ford, and R Wooster, and L A Cannon-Albright, and M R Stratton, and D E Goldgar
December 1995, Journal of medical genetics,
Copied contents to your clipboard!